Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03280667
Title Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma (KEYPAD)
Acronym KEYPAD
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Border Medical Oncology Research Unit Albury New South Wales 2640 Australia Details
Northern Cancer Institute Frenchs Forest New South Wales 2086 Australia Details
Calvary Mater Newcastle Newcastle New South Wales 2298 Australia Details
St Vincent's Hospital Sydney Sydney New South Wales 2010 Australia Details
St George Sydney New South Wales 2229 Australia Details
Concord Repatriation General Hospital Sydney New South Wales Australia Details
Sunshine Coast University Hospital Birtinya Queensland 4575 Australia Details
Icon Cancer Care Brisbane Queensland Australia Details
Royal Brisbane and Womens hospital Herston Queensland 4029 Australia Details
Townsville Hospital Townsville Queensland 4814 Australia Details
Flinders Medical Centre Adelaide South Australia Australia Details
Box Hill Box Hill Victoria 3128 Australia Details
Monash Health Melbourne Victoria Australia Details
Peter MacCallum Cancer Center Melbourne Victoria Australia Details
Ballarat Oncology & Haematology Services Wendouree Victoria Australia Details
Fiona Stanley Hospital Perth Western Australia 6150 Australia Details
*Shaded cells indicate that there was no data available from for the field